Research
The Division is actively conducting various research projects under the oversight of its Cardiovascular Research Unit (CRU). The CRU provides the Division of Cardiovascular Medicine with expertise and support in protocol development, protocol coordination, centralized oversight and data quality control for Cardiology Clinical Trials.
The CRU team includes our clinical manager, multiple research coordinators, senior research associate, data management coordinator and biostatistician.
Our faculty are actively involved in a variety of clinical trials with areas of research including carotid artery disease, coronary artery disease, ischemic heart disease and myocardial infarction, congenital heart disease, heart failure and electrophysiological heart disorders.
The CRU specializes in cutting-edge technology for pacemaker and cardiac devices and oversees all investigator-initiated, federal, foundation and industry-sponsored studies in the Division of Cardiovascular Medicine, working closely with the USC Clinical Trials Office (CTO), Department of Contracts and Grants (DCG) and the USC Health Sciences Campus Institutional Review Board (IRB).
The Division also has an active technology development program and has worked closely with the USC Stevens Institute for Innovation and outside entities to develop new technology and use of modern communication modalities to diagnose cardiovascular disease and fully engage patients and patients’ families and caregivers. Currently, the Division has 48 federal, foundation and industry sponsored protocols and 10 investigator-initiated protocols.